• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.22 Down 0.01(2.52%) Feb 5, 4:00PM EST
    Prev Close:0.23
    Open:0.22
    Bid:0.22 x 9700
    Ask:0.23 x 13300
    1y Target Est:2.50
    Beta:1.1736
    Earnings Date:Mar 7 - Mar 11 (Est.)
    Day's Range:0.22 - 0.23
    52wk Range:0.21 - 0.72
    Volume:193,380
    Avg Vol (3m):480,932
    Market Cap:20.27M
    P/E (ttm):N/A
    EPS (ttm):-0.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUCDown 2.52%20.27M
    STMLDown 2.72%77.22M
    AGENDown 1.64%259.17M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.15
    Quarterly EPS Est (Dec-15) :-0.06
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback